Ascendis Pharma A Income Statement (2012-2026) | ASND

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.00B	0.00B	0.10B	0.01B	0.01B	0.02B	0.02B	0.04B	0.05B	0.05B	0.33B	0.10B	0.04B	0.06B	0.33B	0.11B	0.18B	0.25B	0.48B	0.29B
Cost of Revenue (Quarter)			0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B	0.02B	0.04B	0.03B	0.03B	0.02B
Gross Profit (Quarter)	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.02B	0.03B	0.04B	0.04B	0.13B	0.10B	0.03B	0.05B	0.17B	0.09B	0.14B	0.22B	0.26B	0.27B
Operating items
Research & Development (Quarter)	0.10B	0.07B	0.08B	0.09B	0.10B	0.10B	0.11B	0.11B	0.11B	0.12B	0.10B	0.08B	0.09B	-0.08B	-0.08B	-0.09B	0.08B	-0.08B	-0.09B	-0.07B
Selling, General & Administrative (Quarter)	0.04B	0.05B	0.06B	0.05B	0.06B	0.06B	0.06B	0.07B	0.08B	0.07B	0.07B	0.07B	0.08B	-0.08B	-0.09B	-0.11B	0.12B	-0.13B	-0.16B	-0.17B
Restructuring Costs (Quarter)			-0.02B	-0.12B	-0.00B	0.00B	-0.00B									-0.02B
Other Operating Expenses (Quarter)			-0.24B				-0.27B				-0.23B				0.14B				0.14B
Operating Expenses (Quarter)	0.14B	0.12B	-0.13B	0.03B	0.16B	0.16B	-0.10B	0.19B	0.19B	0.19B	-0.06B	0.15B	0.17B	-0.16B	-0.03B	-0.22B	0.20B	-0.21B	-0.11B	-0.24B
Operating Income (Quarter)	-0.14B	-0.11B	-0.13B	-0.14B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.04B	-0.05B	-0.14B	-0.11B	409.27B	-0.11B	-0.06B	0.01B	0.01B	0.03B
EBIT (Quarter)	-0.14B	-0.11B	-0.13B	-0.14B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.04B	-0.05B	-0.14B	-0.11B	409.27B	-0.11B	-0.06B	0.01B	0.01B	0.03B
Non-operating items
Non Operating Interest Expenses (Quarter)
Interest & Investment Income (Quarter)	0.00B	0.03B	0.02B	0.01B	0.08B	0.02B	0.00B	0.05B	0.04B	0.00B	0.04B	0.00B	0.05B	0.03B	0.09B	0.03B	0.06B	0.01B	0.21B	0.01B
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)			0.02B				0.03B				0.04B				0.09B				0.21B
Net income details
EBT (Quarter)	-0.16B	-0.09B	-0.12B	-0.14B	-0.09B	-0.17B	-0.21B	-0.12B	-0.13B	-0.18B	-0.09B	-0.14B	-0.12B	-0.11B	-0.04B	-0.10B	-0.04B	-0.07B	-0.03B	-0.06B
Tax Provisions (Quarter)	-0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.00B	0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.79B
Profit After Tax (Quarter)	0.00B	-0.00B	-0.12B	-0.14B	-0.09B	-0.17B	-0.21B	-0.12B	-0.13B	-0.18B	-0.09B	-0.14B	0.12B	-0.11B	-0.04B	-0.10B	-0.04B	-0.07B	-0.04B	0.74B
Equity Income (Quarter)	-0.01B	-0.00B	0.04B	-0.01B	-0.00B	-0.00B	-0.01B	-0.00B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	0.03B	-0.00B	-0.01B	0.00B	-0.01B
Income from Non-Controlling Interests (Quarter)	0.00B	0.00B		0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B		0.00B
Income from Continuing Operations (Quarter)	-0.16B	-0.09B	-0.12B	-0.14B	-0.09B	-0.17B	-0.20B	-0.12B	-0.13B	-0.18B	-0.08B	-0.14B	-0.12B	-0.11B	-0.04B	-0.10B	-0.04B	-0.06B	-0.02B	0.74B
Consolidated Net Income (Quarter)	-0.16B	-0.09B	-0.12B	-0.14B	-0.09B	-0.17B	-0.20B	-0.12B	-0.13B	-0.18B	-0.08B	-0.14B	-0.12B	-0.11B	-0.04B	-0.10B	-0.04B	-0.06B	-0.02B	0.74B
Income towards Parent Company (Quarter)	0.16B	0.09B	-0.12B	-0.14B	-0.09B	-0.17B	-0.21B	-0.12B	0.13B	-0.18B	-0.10B	0.14B	0.12B	-0.11B	-0.04B	-0.10B	-0.05B	-0.07B	-0.04B	0.74B
Net Income towards Common Stockholders (Quarter)	0.16B	0.09B	-0.12B	-0.14B	-0.09B	-0.17B	-0.21B	-0.12B	0.13B	-0.18B	-0.10B	0.14B	0.12B	-0.11B	-0.04B	-0.10B	-0.05B	-0.07B	-0.04B	0.74B
Additional items
EPS (Basic) (Quarter)	3.01	1.73	-2.22	-2.48	-1.56	-3.08	-3.77	-2.14	2.37	-3.14	-1.69	2.50	2.05	-1.89	-0.71	-1.66	-0.76	-1.22	-0.65	12.22
EPS (Diluted) (Quarter)	3.89	2.27	-2.91	-3.38	-2.10	-4.14	-5.08	-2.88	3.20	-4.24	-2.28	3.42	1.94	-1.89	-0.71	-1.66	-0.71	-1.20	-0.65	11.47
Shares Outstanding (Quarter)	0.05B	0.05B	0.05B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B
Shares Outstanding (Diluted) (Quarter)	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B
EBITDA (Quarter)	-0.14B	-0.11B	-0.13B	-0.14B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.04B	-0.05B	-0.14B	-0.11B	409.27B	-0.11B	-0.06B	0.01B	0.01B	0.03B
Interest Expenses (Quarter)	0.01B	0.00B	-0.00B	0.01B	0.01B	0.04B	-0.00B	0.01B	0.01B	0.03B	0.01B	0.08B	0.02B	-0.03B	-0.00B	0.05B	0.04B	-0.08B	0.41B	0.08B
Tax Rate (Quarter)	0.05%	-0.01%	0.11%	0.19%	-0.06%	-0.10%	2.65%	1.18%	-0.35%	0.40%	7.14%	1.95%	0.21%	1.04%	2.90%	1.13%	10.99%	6.30%	25.68%	1,406.31%

Research Tools

Developers

Ascendis Pharma A Income Statement (2012-2026) | ASND

Research Tools

Developers

Ascendis Pharma A Income Statement (2012-2026) | ASND

Create an account

Sign In

Reset Password